Table 2

Confirmation of aggregate liquidity

Line

σ21

F2/F1

<a onClick="popup('http://www.biomedcentral.com/1471-2407/12/94/mathml/M1','MathML',630,470);return false;" target="_blank" href="http://www.biomedcentral.com/1471-2407/12/94/mathml/M1">View MathML</a>

P


JHU

0.95 ± 0.03

1.43 ± 0.02

1.54 ± 0.07

< 0.05


AT-2

1.11 ± 0.02

1.43 ± 0.02

1.29 ± 0.03

< 0.05


MLL

1.00 ± 0.04

1.45 ± 0.03

1.45 ± 0.07

< 0.05


MLL-X5C2

1.13 ± 0.04

1.52 ± 0.07

1.39 ± 0.11

< 0.05


MLL-X5C5

1.01 ± 0.08

1.45 ± 0.03

1.57 ± 0.07

< 0.05


Rat 2

1.14 ± 0.05

1.60 ± 0.06

1.40 ± 0.15

< 0.05


Jia et al. BMC Cancer 2012 12:94   doi:10.1186/1471-2407-12-94

Open Data